Sagimet Biosciences director George Kemble disposes of USD 140,548 in common shares - SGMT News | RalliesSagimet Biosciences director George Kemble disposes of USD 140,548 in common shares
S
SGMT• Director sells shares
- Sagimet Biosciences director George Kemble sold 18,844 shares of Series A Common Stock on July 20, 2026.
- Sale priced at USD 7.46 per share on a weighted-average basis.
- He reported 62,161 shares owned following the transaction.
E
ES Bancshares Q2 FY26 net income drops to $882,000; net interest margin widens 4 bps to 3.1%
ESBS•
